Every AI vendor claims their tool is easy to implement and immediately valuable. Lab managers evaluating AI tools for laboratory use are rarely given the framework to test those claims systematically, and without one, purchasing decisions depend on polished demos rather than evidence. The questions vendors prefer you don't ask are usually the most diagnostic, and a well-designed proof of concept (PoC) will reveal more in four weeks than six months of sales presentations.
Quick take
- AI tool evaluation in the lab requires a structured framework that goes beyond vendor-supplied benchmarks and focuses on real-world workflow integration.
- A meaningful PoC uses the lab's own data, tests for failure modes, and defines acceptance criteria before the vendor sets foot in the building.
- Model transparency and explainability directly affect how confidently lab managers can act on AI outputs and defend results to stakeholders.
- Vendor support commitments, update schedules, and model retraining policies carry as much operational weight as the tool's initial accuracy figures.
- Red flags in AI lab tool marketing are predictable and learnable; recognizing them protects procurement budgets and implementation timelines.
Defining your lab AI tool requirements before vendor conversations begin
The single most effective step in evaluating AI tools for laboratory use is completing an internal requirements document before any vendor contact. This document forces specificity about the workflow problem being solved, the data inputs the tool will consume, the outputs required, and the tolerance for error in each direction.
A false negative in an anomaly detection system carries a different operational cost than a false positive: the first misses a real problem; the second triggers unnecessary investigation. Knowing which failure mode is more costly is a prerequisite for evaluating whether any AI tool meets the lab's actual risk threshold. Requirements that remain vague at the start of procurement almost always produce disappointment at go-live.
The requirements document should also specify integration constraints: which laboratory information management system (LIMS) or informatics platforms the AI tool must connect to, what data formats it consumes, and whether on-premises deployment, cloud hosting, or a hybrid architecture is required. Labs considering AI across multiple workflow areas can use an AI strategy framework to sequence requirements by priority and operational readiness before evaluating any single tool.
Questions to ask when evaluating AI lab software
Vendor demonstrations are optimized for favorable conditions. The questions that shift those conditions reveal the actual limits of the tool's capability.
Ask the vendor to demonstrate performance on data outside their canonical training examples, specifically data from a similar lab context that the system has not seen before. Ask how accuracy changes when sample volumes shift, when instrument calibration drifts, or when run conditions deviate from the norm. Any vendor who cannot demonstrate degraded-condition performance has not stress-tested their own system; the lab will be the first to find those limits after purchase.
Request the training data provenance: what datasets were used to train the model, how old they are, and whether any data from labs with workflows similar to the purchasing lab's were included. Models trained on datasets that do not represent the lab's instrument mix, sample types, or throughput profile will underperform, often significantly, regardless of published accuracy figures. The NIST AI Risk Management Framework identifies validity and reliability as foundational trustworthiness properties of any AI system, meaning that performance on training data alone does not establish that a system will perform reliably in a new operational context.
A peer-reviewed systematic review of AI evaluation frameworks in health care found that existing approaches focus heavily on technical accuracy metrics while underweighting real-world integration, workflow fit, and economic sustainability, which are often the factors that determine whether a tool succeeds or fails in practice. Lab managers evaluating AI tools benefit from AI evaluation criteria that extend beyond benchmark performance to organizational fit and long-term viability.
Lab Quality Management Certificate
The Lab Quality Management certificate is more than training—it’s a professional advantage.
Gain critical skills and IACET-approved CEUs that make a measurable difference.
How to run a proof of concept for AI lab tools
A PoC that uses vendor-supplied data, runs on vendor-managed infrastructure, and is assessed against vendor-defined metrics is a demonstration, not a test. A meaningful PoC in laboratory AI evaluation transfers control of those three variables to the purchasing lab.
The following framework defines the minimum elements of a credible PoC:
Validate your software before deployment with this essential, five-step Proof of Concept checklist designed for rigorous laboratory environments.
GEMINI (2026)
- 1. Use the lab's own historical data. Export a representative sample covering normal operations, known failure events, and edge cases. The proportion of abnormal-to-normal events in the test set should match real operational frequency, not be artificially balanced.
- 2. Define acceptance criteria in writing before the PoC begins. Specify the minimum sensitivity, specificity, false-positive rate, and processing time the tool must achieve. Any metric added after the PoC begins is a concession to vendor pressure.
- 3. Run the PoC in the lab's environment. Request a sandboxed deployment in the lab's IT environment rather than the vendor's cloud tenant. Data residency and security requirements are tested simultaneously.
- 4. Include a stress test. Introduce a known anomaly, known instrument drift event, or known out-of-specification result and confirm the tool detects it at the published sensitivity level.
- 5. Assess the output usability, not just the output accuracy. An alert that is technically correct but lacks enough context for a bench scientist to act on is operationally useless. Test whether the tool's outputs are interpretable by the staff who will receive them.
The PoC period should run long enough to capture real operational variability; four to six weeks is a reasonable minimum for most lab workflows. Research on AI implementation in clinical settings consistently finds that deployment takes longer than vendors project, with integration, governance review, and data preparation consuming more time than initial estimates allow. Building realistic timelines into the PoC plan and overall procurement schedule protects against go-live delays.
Evaluating AI model transparency and explainability
Model transparency refers to how much a vendor discloses about how their AI system produces its outputs. Explainability refers to whether the system can communicate, in terms meaningful to the user, why a specific output was generated. Both matter for laboratory AI adoption, but for different reasons.
Interested in lab design?
Transparency is primarily a procurement and compliance concern. A vendor who cannot or will not disclose what data types trained their model, what the model architecture is at a category level, or how the model will be updated over time is presenting a black box that the lab's quality and compliance teams will need to defend in audits. In regulated labs, the model's behavior over time, and any changes to it, may constitute changes that require assessment or documentation under existing quality management procedures.
Explainability is an operational concern. When an AI tool flags an anomaly, the bench scientist receiving that flag needs enough context to decide what to do next. A system that provides a confidence score without a rationale does not enable informed action; it creates a decision that the scientist must either accept blindly or investigate from scratch. Good explainability design surfaces the inputs that most influenced the output: the specific features or data points that drove the alert.
Lab managers evaluating AI tools should ask vendors directly: "What does the system show the end user when it generates an output, and what is the basis for that output?" The answer distinguishes genuinely transparent tools from those that use explainability language in marketing while providing opaque outputs in practice. A study reviewing more than 1,000 FDA-reviewed AI and machine learning medical devices found that AI transparency reporting averaged just 3.3 out of a possible 17 disclosure criteria, with nearly half of devices reporting no clinical study data at all, a pattern that applies equally to laboratory AI tools operating outside the medical device regulatory pathway.
Support, training, and update commitments
The performance of an AI tool at purchase is not the performance it will deliver after 18 months in operation. Models drift as instrument conditions change, sample populations shift, and the lab's workflow evolves. Understanding what happens to the tool's accuracy over time, and who is responsible for monitoring and correcting it, is as important as the initial benchmark.
Ask vendors for a written commitment covering the following:
| Commitment area | Questions to ask |
|---|---|
| Model updates | How frequently are models retrained? Who triggers retraining? |
| Accuracy monitoring | Does the vendor provide performance dashboards post-deployment? |
| Drift detection | How are users notified when model performance degrades? |
| Support tiers | What is the response time for accuracy-related issues versus technical failures? |
| Staff training | Is initial training included? What about training for new staff? |
| Data governance | Where is lab data stored? How is it used in future model versions? |
The data governance question is particularly important: some AI vendors retain the right to use customer data to improve their models more broadly. Labs with confidentiality obligations, proprietary assay data, or regulatory restrictions on data sharing need to review this clause before signing. Lab informatics platform integration raises additional data governance considerations that should be evaluated in parallel with AI tool selection.
Red flags in AI lab tool marketing
Certain patterns in AI vendor marketing reliably signal either overstated capability or undercooked implementation support. Recognizing them before a contract is signed is straightforward once the patterns are known.
- Accuracy claims without context. A figure such as "98% accuracy" means nothing without knowing the dataset it was measured on, the definition of accuracy used, and the base rate of the condition being detected. Ask for sensitivity, specificity, and positive predictive value measured on an independent dataset.
- "Plug and play" integration language. Any AI tool that describes LIMS or instrument integration as straightforward has not accounted for the variation in LIMS configurations, data formats, and API availability across labs. Ask for a reference list of labs using the same LIMS version with the same integration and contact them directly.
- Benchmark-only validation. Vendors who present only published benchmark performance and no site-specific performance data from customer labs have not accumulated real-world evidence. Peer-reviewed research shows that AI tools validated only on benchmark datasets often underperform substantially in actual clinical and laboratory settings.
- Vague update commitments. A vendor who describes model updates as "continuous improvement" without defining what that means, how updates are tested, and how users are notified is describing an unmanaged process. Model updates in regulated environments may require assessment; open-ended update schedules create compliance exposure.
- Resistance to a structured PoC. Any vendor who resists providing access to their tool for evaluation on the lab's own data is protecting their system from the scrutiny that the lab's procurement process requires. This is the most diagnostic red flag of all.
Evaluating AI tools is a capability that compounds over time
The discipline of evaluating AI tools for laboratory use is not a one-time procurement skill. Labs that develop structured evaluation processes, documented requirements templates, and PoC frameworks accumulate an institutional capability that improves every subsequent AI purchasing decision. The first evaluation is the hardest; each subsequent one is faster and more rigorous.
Building that capability starts with a clear AI strategy that connects individual tool decisions to lab-wide priorities, and with a data infrastructure that is organized enough to support meaningful PoC testing. Labs building that broader strategy for the first time can find the full decision arc covered in a lab AI implementation guide. Labs that skip those foundations often find themselves evaluating AI tools in a vacuum, without the baseline data or workflow documentation needed to measure whether the tool is actually working.
This content includes text that has been generated with the assistance of AI. For more information, view Lab Manager's AI use policy.
